Vertex Summer Intern 2026, Statistical Programming jobs in United States
cer-icon
Apply on Employer Site
company-logo

Vertex Pharmaceuticals · 3 weeks ago

Vertex Summer Intern 2026, Statistical Programming

Vertex Pharmaceuticals is a global biotechnology company focused on tackling serious diseases. They are offering a summer internship program for students pursuing advanced degrees in quantitative sciences, where interns will gain experience in statistical programming and biostatistics while working on meaningful projects.

BiotechnologyHealth CareMedicalPharmaceutical
check
Growth Opportunities
badNo H1BnoteU.S. Citizen Onlynote

Responsibilities

Retrieval-Augmented Generation (RAG) / Tool Calling / Function Calling
Prompt Engineering / Semantic Search / Context Retrieval
LLM Agent / AI Agent / LLM APIs (OpenAI, Azure OpenAI)
Chatbot Development (internal tools) / Embedding Models
R Shiny• • This role requires applied LLM systems tied to R-based analytics tools (Shiny app). Focus on models, not usage
Basic software engineering skills will be a plus, such as the ability to implement key UI features including: File upload/download (Excel, Word, RTF); Dropdown menus, text input fields, editable tables; Dynamic code editor panel (e.g., via {shinyAce}); Workflow navigation (tabs or step-by-step)
(Complementary skills) Knowledge of Clinical Data Flow or Pharma Context, knowledge of data science, SAS, R, or Python
(Complementary skills) NLP, Semantic Search, Embeddings, APIs, Git/GitHub
Enjoy exploring programming details and learning know technologies
Present research results and learnings to the Statistical Programming department and broader audience at departmental seminars and/or company poster sessions
Summarize the work for future departmental use and potentially produce a peer-reviewed publication
Attend seminars and other company activities to enhance the understanding of the drug development process and daily work of either statistical programmers or biostatisticians in a biotechnology company

Qualification

Statistical ProgrammingR ShinyNatural Language ProcessingPythonData ScienceSoftware DevelopmentCommunication SkillsLeadership Skills

Required

Currently enrolled in a graduate-level curriculum leading to a Ph.D. in Computer Science, Statistics or Biostatistics or other quantitative science (e.g., data science, etc.)
Currently enrolled in a Master degree in Computer science, Statistics or Biostatistics or other quantitative science (e.g., data science, etc.)
Be in good academic standing within your graduate program and at your university
Legal authorization to work in the United States, now and in the future. Please note that Vertex does not provide sponsorship for internships or entry level roles within this part of the organization
You must be available to work full-time, 40 hours per week from May – August 2026

Preferred

Possess a tracked record of accomplishment, including publications, awards, presentations, coding projects
Experience with natural language processing and python is preferred but not required
Have excellent communication, presentation, and leadership skills
Have actual project experience in software development
Demonstrated experience with cross-disciplinary application of statistical methods
Genuine interest in clinical development and regulatory affairs

Benefits

Free 24/7 onsite gym access and free access to group exercise classes
Subsidized commuter benefits- transit and parking
Provided meals—free breakfast daily!
Career development opportunities and events, including C Suite engagement
Social events—both intern-only and company-wide
Location-specific perks and extras!
Recognition of National Intern Day
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)

Company

Vertex Pharmaceuticals

company-logo
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

Funding

Current Stage
Public Company
Total Funding
$657.31M
Key Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M

Leadership Team

leader-logo
Reshma Kewalramani
CEO and President
linkedin
leader-logo
Nina Devlin
Senior Vice President, Chief Communications Officer
linkedin
Company data provided by crunchbase